Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PRINCIPEN vs PRINCIPEN '125'
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Ampicillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with transpeptidation, leading to cell lysis.
Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
Infections of the respiratory tract (e.g., sinusitis, bronchitis, pneumonia) caused by susceptible organisms,Infections of the genitourinary tract (e.g., urinary tract infections, gonorrhea) caused by susceptible organisms,Infections of the gastrointestinal tract (e.g., typhoid fever, shigellosis) caused by susceptible organisms,Meningitis caused by susceptible organisms (e.g., Listeria monocytogenes, Neisseria meningitidis),Endocarditis (e.g., enterococcal endocarditis) - in combination with an aminoglycoside,Septicemia caused by susceptible organisms,Prophylaxis of bacterial endocarditis in patients undergoing dental or surgical procedures (off-label in some guidelines)
Treatment of infections caused by susceptible gram-positive and gram-negative bacteria, including respiratory tract infections, otitis media, sinusitis, urinary tract infections, meningitis, septicemia, and gastroenteritis.,Off-label: Prophylaxis for bacterial endocarditis, treatment of listeriosis, and Lyme disease.
250-500 mg orally every 6 hours or 500 mg intravenously every 6 hours for moderate infections; severe infections: 500 mg-1 g every 4-6 hours.
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.
0.5–1 hour; prolonged to 7–10 hours in renal impairment (creatinine clearance <10 m L/min).
Terminal elimination half-life: 0.7-1.4 hours in adults with normal renal function. Prolonged in renal impairment (up to 7-10 hours in anuria).
Ampicillin is partially metabolized by hepatic hydrolysis to penicilloic acid; approximately 90% of an oral dose is excreted unchanged in urine via tubular secretion and glomerular filtration.
Ampicillin is metabolized by hydrolysis to penicilloic acid, primarily in the liver. It also undergoes renal tubular secretion.
Primarily renal (90–100% unchanged) via tubular secretion and glomerular filtration. Minor biliary excretion (<1%).
Renal: approximately 60-80% of the dose excreted unchanged in urine via tubular secretion and glomerular filtration. Biliary/fecal: minimal, <10%.
60–80% bound to albumin.
Approximately 20-30% bound to serum proteins, primarily albumin.
0.3–0.5 L/kg; indicates limited extravascular distribution.
0.3-0.4 L/kg, approximating extracellular fluid volume. Higher in neonates and critically ill patients due to increased extracellular water.
Oral: 30–50% (variable due to gastric acid lability); IM: 70–85%.
Oral: 30-50% due to acid lability and incomplete absorption. IM: nearly 100%.
Cr Cl >50 m L/min: no adjustment; Cr Cl 10-50 m L/min: 250-500 mg every 6-8 hours; Cr Cl <10 m L/min: 250-500 mg every 12 hours; hemodialysis: 250-500 mg every 12 hours, give dose after dialysis.
Cr Cl 10-50 m L/min: Administer every 6-12 hours. Cr Cl <10 m L/min: Administer every 12-16 hours.
No adjustment required for mild to moderate hepatic impairment; caution in severe hepatic disease due to potential for accumulation, but specific Child-Pugh adjustments not established.
No dose adjustment required.
Neonates 0-7 days: 50-100 mg/kg/day IV divided every 12 hours; Infants 1-4 weeks: 75-150 mg/kg/day IV divided every 8 hours; Children >1 month: 25-50 mg/kg/day orally divided every 6 hours, or 100-200 mg/kg/day IV divided every 4-6 hours; maximum 12 g/day.
Infants and children: 12.5-25 mg/kg orally every 6 hours. For severe infections: up to 50 mg/kg/day in divided doses every 6 hours.
No specific dose adjustment required; consider age-related renal impairment and adjust based on renal function; monitor for electrolyte disturbances and neurotoxicity.
Dose based on renal function; use lower end of dosing interval due to age-related decline in renal function.
None
No FDA black box warning.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have been reported; discontinue therapy if reaction occurs.,Clostridium difficile-associated diarrhea (CDAD) may occur, ranging in severity from mild diarrhea to fatal colitis.,Prolonged use may result in overgrowth of nonsusceptible organisms (e.g., Candida).,Use with caution in patients with renal impairment; dose adjustment may be necessary.,Use with caution in patients with history of allergies (e.g., asthma, hay fever, urticaria) due to increased risk of hypersensitivity.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have occurred.,Clostridium difficile-associated diarrhea (CDAD) reported with nearly all antibacterial agents.,Prolonged use may result in overgrowth of nonsusceptible organisms including fungi.,Dosage adjustment required in renal impairment.,Safety in pregnancy: Category B; use only if clearly needed.
Hypersensitivity to ampicillin or any other beta-lactam antibiotic (e.g., penicillins, cephalosporins),Infectious mononucleosis (high incidence of maculopapular rash)
Hypersensitivity to penicillins, cephalosporins, or other beta-lactam antibiotics.,Infections caused by beta-lactamase-producing organisms (ampicillin is susceptible to beta-lactamase degradation).
Food decreases absorption; take on an empty stomach. Avoid acidic beverages (e.g., citrus juices) which may degrade the drug. No specific dietary restrictions.
Take on an empty stomach. Food, especially acidic beverages or fruit juices, may reduce absorption. Avoid alcohol concurrently. No specific dietary restrictions.
FDA Pregnancy Category B. Animal studies have not revealed evidence of fetal harm. No adequate, well-controlled studies in pregnant women. However, penicillin-class antibiotics are generally considered low risk. First trimester: No documented teratogenicity. Second and third trimesters: No documented fetal adverse effects. Use only if clearly needed.
FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Inadequate human data in first trimester; risk cannot be excluded. Penicillins are generally considered low risk throughout pregnancy.
Ampicillin is excreted into human breast milk in low concentrations (M/P ratio approximately 0.2-0.3). The American Academy of Pediatrics considers ampicillin compatible with breastfeeding. Potential for alteration of infant gut flora and interference with culture results if febrile. Use caution in infants with known penicillin allergy.
Excreted into breast milk in low amounts (M/P ratio approximately 0.5). Considered compatible with breastfeeding; monitor infant for rash, diarrhea, or candidiasis.
No clinically significant pharmacokinetic changes requiring dose adjustment in pregnancy. Standard adult dosing is appropriate. For severe infections, higher doses may be needed due to increased volume of distribution and renal clearance, but no specific dose adjustment is routinely recommended.
No significant pharmacokinetic changes requiring dose adjustment. Increased renal clearance and expanded plasma volume may lower serum concentrations, but standard dosing remains effective. Adjust only if renal function significantly declines.
Principen (ampicillin) is a penicillinase-sensitive penicillin. For empiric coverage, consider local resistance patterns; many E. coli and H. influenzae isolates are resistant. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Monitor for hypersensitivity reactions, especially in patients with penicillin allergy. Use with caution in mononucleosis due to high rash incidence.
Principen '125' (ampicillin) is a broad-spectrum penicillin. Note that it is inactivated by beta-lactamases; use with a beta-lactamase inhibitor for resistant organisms. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Monitor for hypersensitivity reactions, especially rash; ampicillin rash is common in patients with Epstein-Barr virus or concurrent allopurinol use. Adjust dose in renal impairment (Cr Cl <30 m L/min).
Take on an empty stomach, at least 1 hour before or 2 hours after meals.,Complete the full course even if you feel better.,Notify your doctor if you develop a rash, diarrhea, or difficulty breathing.,Do not take if you are allergic to penicillins or cephalosporins.,Store capsules and oral suspension at room temperature; discard unused suspension after 14 days.
Take this medication on an empty stomach, at least 1 hour before or 2 hours after meals.,Complete the entire prescribed course even if you feel better.,Inform your doctor if you develop a rash, diarrhea, or signs of an allergic reaction.,Avoid alcohol while taking ampicillin to reduce side effects.,Use effective contraception if applicable; ampicillin may reduce oral contraceptive efficacy.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PRINCIPEN vs PRINCIPEN '125', answered by our medical review team.
PRINCIPEN is a Aminopenicillin Antibiotic that works by Ampicillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with transpeptidation, leading to cell lysis.. PRINCIPEN '125' is a Aminopenicillin Antibiotic that works by Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PRINCIPEN and PRINCIPEN '125' depend on the specific clinical indication. These are both Aminopenicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PRINCIPEN is: 250-500 mg orally every 6 hours or 500 mg intravenously every 6 hours for moderate infections; severe infections: 500 mg-1 g every 4-6 hours.. The standard adult dose of PRINCIPEN '125' is: 250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PRINCIPEN and PRINCIPEN '125' in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PRINCIPEN is classified as Category C. FDA Pregnancy Category B. Animal studies have not revealed evidence of fetal harm. No adequate, well-controlled studies in pregnant women. However, penicillin-class antibiotics are. PRINCIPEN '125' is classified as Category C. FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Inadequate human data in first trimester; risk cannot be excluded. Penicillins are generally considered l. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.